USD 14.48
(-4.49%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -1.2 Million USD | 89.27% |
2022 | -11.24 Million USD | -1944.36% |
2021 | -550 Thousand USD | 17.29% |
2020 | -665 Thousand USD | 0.15% |
2019 | -666 Thousand USD | -0.15% |
2018 | -665 Thousand USD | 0.0% |
2017 | -665 Thousand USD | 0.0% |
2016 | -665 Thousand USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | -267 Thousand USD | -0.38% |
2024 Q2 | -266 Thousand USD | 11.04% |
2024 Q1 | -299 Thousand USD | -120.82% |
2023 FY | -1.2 Million USD | 89.27% |
2023 Q4 | 1.43 Million USD | 639.85% |
2023 Q3 | -266 Thousand USD | 11.92% |
2023 Q1 | -302 Thousand USD | 76.77% |
2023 Q2 | -302 Thousand USD | 0.0% |
2022 Q3 | -8.4 Million USD | -678.5% |
2022 Q2 | -1.07 Million USD | -132.04% |
2022 FY | -11.24 Million USD | -1944.36% |
2022 Q1 | -465 Thousand USD | -17.13% |
2022 Q4 | -1.3 Million USD | 84.52% |
2021 Q2 | -266 Thousand USD | 5.0% |
2021 Q4 | -397 Thousand USD | -159.48% |
2021 Q1 | -280 Thousand USD | 0.0% |
2021 FY | -550 Thousand USD | 17.29% |
2021 Q3 | -153 Thousand USD | 42.48% |
2020 Q4 | - USD | 100.0% |
2020 Q1 | -166 Thousand USD | 0.0% |
2020 Q2 | -167 Thousand USD | -0.6% |
2020 Q3 | -166 Thousand USD | 0.6% |
2020 FY | -665 Thousand USD | 0.15% |
2019 Q1 | -167 Thousand USD | 0.0% |
2019 FY | -666 Thousand USD | -0.15% |
2019 Q4 | - USD | 100.0% |
2019 Q3 | -166 Thousand USD | 0.0% |
2019 Q2 | -166 Thousand USD | 0.6% |
2018 Q3 | -166 Thousand USD | 0.6% |
2018 Q2 | -167 Thousand USD | -0.6% |
2018 FY | -665 Thousand USD | 0.0% |
2018 Q1 | -166 Thousand USD | 0.0% |
2018 Q4 | - USD | 100.0% |
2017 Q2 | -167 Thousand USD | -0.6% |
2017 Q1 | -166 Thousand USD | 0.0% |
2017 Q3 | -166 Thousand USD | 0.6% |
2017 Q4 | - USD | 100.0% |
2017 FY | -665 Thousand USD | 0.0% |
2016 Q1 | -166 Thousand USD | 0.0% |
2016 FY | -665 Thousand USD | 0.0% |
2016 Q4 | - USD | 100.0% |
2016 Q3 | -166 Thousand USD | 0.0% |
2016 Q2 | -166 Thousand USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Akoya Biosciences, Inc. | 56.3 Million USD | 102.144% |
AngioDynamics, Inc. | 154.69 Million USD | 100.78% |
AtriCure, Inc. | 300.37 Million USD | 100.402% |
Avinger, Inc. | 2 Million USD | 160.26% |
Azenta, Inc. | 263.14 Million USD | 100.459% |
BioLife Solutions, Inc. | 46.75 Million USD | 102.582% |
The Cooper Companies, Inc. | 2.35 Billion USD | 100.051% |
Daxor Corporation | 1.1 Million USD | 209.385% |
Ekso Bionics Holdings, Inc. | 9.07 Million USD | 113.294% |
Femasys Inc. | 691.9 Thousand USD | 274.447% |
GlucoTrack, Inc. | -13 Thousand USD | -9184.615% |
Harvard Bioscience, Inc. | 60.86 Million USD | 101.983% |
Hologic, Inc. | 2.22 Billion USD | 100.054% |
ICU Medical, Inc. | 739.87 Million USD | 100.163% |
Intuitive Surgical, Inc. | 4.72 Billion USD | 100.026% |
KORU Medical Systems, Inc. | 16.7 Million USD | 107.224% |
LeMaitre Vascular, Inc. | 127.04 Million USD | 100.95% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | -911.489% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | -911.489% |
Masimo Corporation | 1 Billion USD | 100.12% |
Microbot Medical Inc. | -106 Thousand USD | -1038.679% |
Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 103.647% |
Merit Medical Systems, Inc. | 583.87 Million USD | 100.207% |
Nephros, Inc. | 8.4 Million USD | 114.36% |
NovoCure Limited | 381.05 Million USD | 100.317% |
NEXGEL, Inc. | 619 Thousand USD | 294.992% |
NEXGEL, Inc. | 619 Thousand USD | 294.992% |
Singular Genomics Systems, Inc. | -558 Thousand USD | -116.308% |
OraSure Technologies, Inc. | 179.42 Million USD | 100.673% |
Pro-Dex, Inc. | 14.55 Million USD | 108.295% |
Predictive Oncology Inc. | 1.14 Million USD | 205.388% |
Precision Optics Corporation, Inc. | 5.79 Million USD | 120.818% |
QuidelOrtho Corporation | 1.49 Billion USD | 100.081% |
Repligen Corporation | 315.22 Million USD | 100.383% |
Sanara MedTech Inc. | 57.13 Million USD | 102.112% |
STAAR Surgical Company | 252.65 Million USD | 100.478% |
Sharps Technology, Inc. | -891.24 Thousand USD | -35.428% |
Utah Medical Products, Inc. | 30.03 Million USD | 104.018% |
DENTSPLY SIRONA Inc. | 2.08 Billion USD | 100.058% |
Jin Medical International Ltd. | 6.78 Million USD | 117.79% |